Drug application
QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)
Drugs@FDA ANDA 206260 · PHARMADAX
Key facts
| Drug name | QUETIAPINE FUMARATE |
|---|---|
| Active ingredients | QUETIAPINE FUMARATE |
| Application type | ANDA |
| Application number | 206260 |
| Company | PHARMADAX |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | EQ 50MG BASE |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | May 9, 2017 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: